Nocebo in Biosimilars and Generics in Neurology: A Systematic Review

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00809
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Pmu4 - The Safety of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence

BioDrugs
MedicineBiotechnologyPharmacology
2017English

P.112 Hospital Readmission Following Neurology Discharge: A Systematic Review

Canadian Journal of Neurological Sciences
MedicineNeurology
2018English

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence

BioDrugs
MedicineBiotechnologyPharmacology
2016English

Comment On: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

Drugs
Pharmacology
2018English

Pgi9 - Systematic Review and Meta-Analysis of the Efficacy of Infliximab Biosimilars in Inflammatory Bowel Disease Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Generics and Reverse Generics for Pharo

2012English

Kinds, Things, and Stuff: Mass Terms and Generics (Review)

Language
LinguisticsLanguage
2011English

Adalimumab: A Review of the Reference Product and Biosimilars

Biosimilars
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy